The liver plays a key regulatory role in cholesterol metabolism. Two proteins are central in this role; the LDL receptor and 3-hydroxy-3-methylglutaryl CoA reductase (HMG CoA reductase), the rate-limiting enzyme in cholesterol biosynthesis. In the current investigation, we have used a sensitive nonradioactive method to study the regulation of LDL receptor and HMG CoA reductase mRNA levels in liver biopsy samples and freshly isolated mononuclear leukocytes from 13 patients who underwent cholecystectomy for gallstones. mRNA copy numbers were determined by PCR amplification of reversetranscribed RNA using synthetic RNA as an internal standard. Incorporation of digoxigenin-11-dUTP during amplification allowed direct detection and quantitation of mRNA levels by chemiluminescence. These experiments showed that the average number of LDL receptor mRNA molecules in liver (21±3 X 104/,gg of RNA) and mononuclear leukocytes (24±3 X 104/ ,ug of RNA) are indistinguishable, whereas the number of HMG CoA reductase molecules in liver (107±15 X 10'/,ug of RNA) is smaller than that in mononuclear leukocytes (158±21 x 104/,g of RNA, P < 0.05). These numbers correspond to an average of 1-6 copies of LDL receptor mRNA and 542 copies of HMG CoA reductase mRNA per cell. There was a significant correlation between the numbers of LDL receptor (P = 0.0005) and HMG CoA reductase (P = 0.003) mRNA molecules in liver and mononuclear leukocytes. Furthermore, the numbers of copies of HMG CoA reductase and LDL receptor mRNA were correlated with each other in both liver (P = 0.02) and mononuclear leukocytes (P = 0.01), consistent with coordinate regulation. These data demonstrate that the mechanisms which regulate mRNA levels in liver and mononuclear cells are similar and suggest that freshly isolated mononuclear cells can be used to predict HMG CoA reductase and LDL receptor mRNA levels in liver. (J. Clin. Invest. 1994. 93:2168-2174 
Introduction
The liver plays a central role in cholesterol metabolism, integrating lipoprotein-dependent cholesterol fluxes and the enterohepatic circulation of bile acids and cholesterol (1) . Much of our current knowledge about how the hepatocyte achieves this is based on experiments with cultured cells. These studies have shown that cells, including hepatocytes, respond to cholesterol influx and efflux by regulating the activities of 3-hydroxy-3-methylglutaryl CoA reductase (HMG CoA reductase),' the rate-limiting enzyme in cholesterol biosynthesis, and of the LDL receptor (2) . These activities are regulated coordinately and act to maintain intracellular cholesterol levels within narrow limits. The promoters of the HMG CoA reductase and LDL receptor genes contain sterol-responsive elements which are believed to be responsible for the coordinate nature ofthese regulatory processes (3) .
Recent studies have begun to focus on the in vivo regulation of HMG CoA reductase and the LDL receptor in human liver. However such studies are often hampered by the difficulty in obtaining human liver samples. One readily accessible source of cells that are exposed to the same external environment as hepatocytes is circulating mononuclear leukocytes. Since the basic regulatory mechanisms in liver and mononuclear leukocytes are similar, we hypothesized that the expression of LDL receptor and HMG CoA reductase genes in these cells may occur in parallel and that the measurement of gene expression in human mononuclear leukocytes may be predictive of gene expression in liver.
We have recently adapted a method of Wang et al. (4) to quantitate mRNA levels in small tissue samples available from in vivo sources (5) . We used this technique in the present study to examine the relationship between LDL receptor and HMG CoA reductase mRNA levels in the human liver and in peripheral blood mononuclear cells as a measure of gene expression in these cells. Methods Subjects and sample collection. The study comprised 13 patients who underwent cholecystectomy for symptomatic gallstones. Individual characteristics including lipid parameters and use of estrogen/progesterone values are summarized in Table I . All subjects were well at the time of the study and had no additional medical problems apart from mild systemic hypertension in patients 3 and 5. Full blood counts were normal with the exception of one subject who had a mild increase in polymorphonuclear cell count. Three of the nine women were taking estrogen and progesterone preparations. Informed written consent was obtained from each patient before surgery, and the study protocol was approved by the Royal Brisbane Hospital Ethics Committee.
Surgery was performed after an 8-h fast. Immediately before induction of anesthesia, venous blood ( 10 ml) was collected for the isolation of mononuclear cells and determination of serum lipoproteins. After the abdomen was opened, a small wedge or 2-cm tru-cut biopsy was taken from the liver. Halfofthis sample was placed immediately in 1.5 ml of a 4 M guanidine isothiocyanate solution (4 M guanidinium isothiocyanate, 20 mM sodium acetate, pH 5.2, 0.1 mM DTT, 0.5% Nlauryl sarcosine) and homogenized in a microcentrifuge tube with a hand-held pestle. After centrifugation in a microcentrifuge (Heraeus; Sepatech GmbH, Osterode, Germany) at 12,000 rpm for 10 min, the supernatant was removed and frozen immediately in liquid nitrogen. Samples were stored at -70'C until required. Examination of the remainder of the liver biopsy samples showed normal histology with the following exceptions: one subject had pathological findings consistent with steatohepatitis, and two subjects had a moderate degree of fatty infiltration of the liver. Mononuclear cells were isolated by centrifugation of whole blood on a Ficoll gradient as described previously (6) . Analysis of several samples by flow cytometry and differential cell counting revealed a cell population that consisted of 85-90% lymphocytes. The mononuclear leukocyte preparations were lysed immediately in 4 M guanidinium isothiocyanate, frozen in liquid nitrogen, and stored at -70'C until required.
RNA preparation. Total cellular RNA was prepared from the mononuclear leukocytes and liver samples by centrifugation ofthe 4 M guanidinium isothiocyanate extracts through a 5.7 M cesium chloride cushion as described previously (5 (Fig. 1 ). An RNA-PCR kit (Perkin-Elmer Cetus Instruments) was used for this reaction according to procedures included, except that the concentration of dTTP was reduced from 1 to 0.975 mM to allow the incorporation ofdigoxigenin-l l-dUTP (DIG) (Boehringer Mannheim Corp., Indianapolis, IN) as a nonisotopic label during PCR amplification of the reverse-transcribed RNA. PCR was performed as described in procedures provided with the RNA-PCR kit, except that 14-25 MM DIG was included, and 10 ,l of the reverse transcription reaction mixture was used in a total reaction volume of 50 Ml. A total of 15 pmol each of 5' and 3 LDL receptor or HMG CoA reductase primers was added to the PCR mixture. The primer sequences are shown in Table II . The mixture was overlaid with 20 Ml of Nujol mineral oil (Cetus Corp., Berkeley, CA) and amplified with a fast thermal sequencer (FTS-1; Corbet Research, Sydney, Australia) for 25 cycles. The amplification profile involved denaturation at 95°C for 30 s, primer annealing at 55°C for 30 s, and extension at 72°C for 1 min.
PCR product detection by chemiluminescence. 10 Ml of each PCR reaction mixture was size fractionated by electrophoresis on 3% agarose (Pharmacia LKB Biotechnology Inc., Piscataway, NJ) gels (10 cm X 7 cm) in Tris/acetate buffer, and transferred to a nylon membrane ( Boehringer Mannheim Corp.) by blotting for 3 h in 10 X SSC (20 X SSC:3 M sodium chloride, 0.3 M sodium citrate, pH 7). The blot was baked under vacuum at 120°C for 20 min and rinsed in 2 X SSC. Detection of the PCR products was performed directly on the nylon membrane using an antidigoxigenin antibody conjugated to alkaline phosphatase (Boehringer Mannheim Corp.). The protocol provided with the reagents was followed directly. Chemiluminescent detection of the antibody conjugate was performed by incubating the membrane for 5 min in a solution of disodium 3-(4-methoxyspiro[1,2-dioxethane-3,2'-tricyclo { 3.3.1. }decan]-4-yl)phenyl phosphate (100 Mg/ml in 0.1 M Tris HCl, 0.1 M sodium chloride, 50 mM magnesium chloride, pH 9.5) (Boehringer Mannheim Corp.). Sharp distinct signals were obtained after exposure for 2-10 min to x-ray film (Agfa Curix MR4).
Quantitation. (5) .
The results of LDL receptor and HMG CoA reductase mRNA measurements in liver and mononuclear leukocytes from all of the subjects in the current study are summarized in Fig. 3 . These data show that the average numbers of LDL receptor mRNA molecules in liver (21±3 X 104/,ug of RNA) Although mononuclear leukocytes and liver differ enormously in their involvement in cholesterol metabolism, the underlying regulatory mechanisms for maintaining cellular cholesterol homeostasis are unlikely to differ significantly. Since both cell types appear to be exposed to a similar external milieu, we addressed the question as to whether LDL receptor and HMG CoA reductase mRNA levels in liver and mononu-50 -LDL Receptor clear leukocytes were correlated. To compare gene expression in liver and mononuclear leukocytes, it was essential to minimize the time between venesection and liver biopsy. In the current studies, the maximum delay was 40 min, with most samples collected within a 25-min period. The first indication that mRNA levels in liver and mononuclear leukocytes from the same subject are related came from the results in Fig. 3 . These data showed that subjects with low (high) LDL receptor or HMG CoA reductase mRNA levels in liver also tended to have low (high) levels in their mononuclear leukocytes. A more direct comparison of the number of LDL receptor mRNA molecules in liver versus mononuclear leukocytes for 10 of the patients in the current study, from whom both liver and mononuclear leukocytes were available, is shown in Fig. 4 . Analysis of the data shows that these LDL receptor mRNA levels are highly correlated (r = 0.89, P = 0.0005). A similar analysis of HMG CoA reductase mRNA levels in liver and mononuclear leukocytes (Fig. 5) demonstrates that HMG CoA reductase mRNA levels in liver and mononuclear leukocytes are also correlated (r = 0.83, P = 0.003). These results show for the first time that changes in mRNA levels for both the LDL receptor and HMG CoA reductase in mononuclear leukocytes and liver occur in parallel and suggest that common regulatory steps exist to maintain this relationship.
A key feature of the regulation of LDL receptor and HMG CoA reductase mRNA levels is the existence of sterol-responsive elements within the promoters ofboth genes (3). Sterol-responsive elements are believed to be responsible for the coordinate transcriptional regulation mediated by sterols in cell culture ( 10) . We addressed the question of whether the LDL receptor and HMG CoA reductase genes were regulated coordinately in vivo. Figs. 6 and 7 show the relationship between LDL receptor and HMG CoA reductase mRNA levels in liver and mononuclear leukocytes, respectively. These data are consistent with coordinate regulation in both the liver (r = 0.69, P = 0.02) and in mononuclear leukocytes (r = 0.68, P = 0.01).
We analyzed the relationship between serum LDL and HDL cholesterol concentrations and the number of LDL re- We conclude that freshly isolated mononuclear leukocytes can ade studies ofits be used to predict the level of expression of the HMG CoA has led investireductase and LDL receptor genes in the liver and that the rpes which may mechanisms which regulate gene expression in liver and mononuclear leukocytes are similar. We note, however, that the correlation between mRNA levels in liver and mononuclear cells involved mostly female patients (9/ 10). While it is unlikely that this relationship is sex dependent, further studies are * required to confirm this.
The close correlation between HMG CoA reductase and LDL receptor mRNA levels in mononuclear leukocytes and liver suggests that there is a common factor or process in the circulation which mediates regulation ofthese mRNAs. Hepatocytes are exposed to the vascular space through the fenes-* k trated sinusoidal endothelium and therefore are exposed to the same milieu as mononuclear leukocytes in the circulation.
However, because lymphocytes, the major cellular component of mononuclear cells, continually move between the vascular space, the spleen, and lymph nodes ( 13) (2) . VLDL remnants provide a significant flux of sterol through the liver; -60% of VLDL remnants is removed by the liver, while the remaining 40% is converted to LDL ( 14, 15) .
The relationship between LDL receptor protein levels and plasma cholesterol levels in humans has been addressed in several studies, with contrasting results. Mistry et al. (16) found no correlation between LDL receptor levels in mononuclear cells and the total or LDL cholesterol concentration in plasma. In contrast, Soutar et al. ( 17) demonstrated a statistically significant inverse correlation between hepatic LDL receptor protein and plasma LDL cholesterol concentrations in 10 cancer patients with low mean cholesterol concentrations. Similarly, a study of hepatic LDL receptor levels during fetal development showed an inverse correlation with plasma LDL concentrations ( 18) .
Despite the fact that LDL is the major source ofcholesterol in the circulation, the relationship between LDL cholesterol concentrations and gene expression is likely to be complex. Plasma LDL concentrations are determined by a combination of hepatic secretion of VLDL and hepatic LDL receptor-dependent removal of VLDL remnants and LDL from the circulation. In contrast, the intracellular concentration ofregulatory sterol is dependent on the cellular influx and efflux of cholesterol. Because the mean concentration of circulating LDL in adults (2.8-3.9 mmol/liter depending on age) is much higher than the apparent Kd (18 nM, which is equivalent to 0.04 mmol cholesterol/liter) of LDL for the LDL receptor (19) , receptor-mediated uptake of LDL is predicted to be proportional to the number of cellular LDL receptors and independent of the plasma LDL concentration. In the current study, contributions to cellular cholesterol pools by chylomicron remnants can be neglected because patients were fasted before surgery. Contributions by receptor-independent uptake, though smaller than receptor-dependent uptake, may depend on the plasma LDL concentration. Assuming that receptor-dependent uptake is dominant, the rate of influx of LDL cholesterol will be constant. To maintain cellular cholesterol homeostasis, this influx must be balanced by an efflux of cholesterol which may play a regulatory role. While efflux from the liver can be mediated by lipoprotein secretion and secretion ofsterol into bile, these mechanisms are not shared with mononuclear cells.
We considered the possibility that effilux mediated by HDLdependent reverse cholesterol transport might be one such shared mechanism (20) . In this way elevated HDL levels may increase the cholesterol efflux from mononuclear leukocytes and hepatocytes and thus increase LDL receptor and HMG CoA reductase mRNA levels. Contrary to our expectations, there was a significant, though weak (P < 0.05), inverse correlation between LDL receptor mRNA levels in both liver and mononuclear leukocytes and HDL cholesterol levels in this patient group. The mechanism responsible for the close correlation between LDL receptor and HMG CoA reductase mRNA levels in liver and mononuclear leukocytes therefore remains to be elucidated.
Coordinate regulation of LDL receptor and HMG CoA reductase mRNAs has been demonstrated clearly in cultured cells ( 10, 2 1). The question of in vivo coordinate regulation has been more controversial. Spady et al. (22) concluded that cholesterol synthesis and receptor-dependent removal of LDL by the liver are regulated independently. The current data are clearly inconsistent with this view, at least for mRNA levels. The number ofcopies ofHMG CoA reductase and LDL receptor mRNA molecules is correlated in both mononuclear leukocytes and liver, consistent with the hypothesis that the HMG CoA reductase and LDL receptor genes are regulated coordinately. Although this is likely because oftranscriptional regulation, the involvement of posttranscriptional regulatory steps cannot be excluded. Irrespective of the mechanisms involved, the current data suggest that liver cells and mononuclear leukocytes respond to an increased demand for cholesterol by increasing the number ofcopies ofLDL receptor and HMG CoA reductase mRNA molecules simultaneously. Recent studies in which hepatic HMG CoA reductase and LDL receptor activities were measured in patients treated with pravastatin and in patients with Crohn's disease have demonstrated that the activities are also correlated (23, 24) .
The current studies have provided the first measurement of the number ofLDL receptor and HMG CoA reductase mRNA molecules in human mononuclear leukocytes and liver cells in vivo. Both liver and mononuclear leukocytes contained between one and six copies of LDL receptor mRNA per cell. A similar number of copies is present in the liver of nonhuman primates (25). The 
